By Nick Johnson (Apyx) In 2025 Shareholder News, J-Plasma, RenuvionPosted August 7, 2025APYX MEDICAL CORPORATION REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4) READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, J-Plasma, RenuvionPosted August 7, 2025APYX MEDICAL EXPANDS GLOBAL SALES LEADERSHIP WITH STRATEGIC HIRES TO SUPPORT AYON LAUNCH AND ACCELERATED GROWTH READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, J-Plasma, RenuvionPosted August 7, 2025APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS READ MORE